Cargando…
Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences
Autores principales: | Gressenberger, Paul, Gary, Thomas, Raggam, Reinhard B., Borenich, Andrea, Brodmann, Marianne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538067/ https://www.ncbi.nlm.nih.gov/pubmed/33046346 http://dx.doi.org/10.1016/j.ejim.2020.10.007 |
Ejemplares similares
-
Lipoprotein(a) and Pulmonary Embolism Severity-A Retrospective Data Analysis
por: Gressenberger, Paul, et al.
Publicado: (2022) -
The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease
por: Guetl, Katharina, et al.
Publicado: (2019) -
Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination
por: Gattringer, Thomas, et al.
Publicado: (2021) -
SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban
por: Guetl, Katharina, et al.
Publicado: (2021) -
Evaluation of Endothelial Dysfunction and Inflammatory Vasculopathy After SARS-CoV-2 Infection—A Cross-Sectional Study
por: Jud, Philipp, et al.
Publicado: (2021)